Exploiting convergent phenotypes to derive a pan-cancer cisplatin response gene expression signature
Abstract Precision medicine offers remarkable potential for the treatment of cancer, but is largely focused on tumors that harbor actionable mutations. Gene expression signatures can expand the scope of precision medicine by predicting response to traditional (cytotoxic) chemotherapy agents without...
Main Authors: | Jessica A. Scarborough, Steven A. Eschrich, Javier Torres-Roca, Andrew Dhawan, Jacob G. Scott |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-04-01
|
Series: | npj Precision Oncology |
Online Access: | https://doi.org/10.1038/s41698-023-00375-y |
Similar Items
-
Exploiting Pan Influenza A and Pan Influenza B Pseudotype Libraries for Efficient Vaccine Antigen Selection
by: Joanne Marie M. Del Rosario, et al.
Published: (2021-07-01) -
On the radius of convergence of the logarithmic signature
by: Lyons, T, et al.
Published: (2006) -
Pan-cancer characterisation of microRNA across cancer hallmarks reveals microRNA-mediated downregulation of tumour suppressors
by: Dhawan, A, et al.
Published: (2018) -
Exploiting the materials signature in cryogenic WIMP detectors
by: Kraus, H, et al.
Published: (2005) -
Pan-cancer characterisation of microRNA with hallmarks of cancer reveals role of microRNA-mediated downregulation of tumour suppressor genes
by: Dhawan, A, et al.
Published: (2018)